0
Skip to Content
Alliance for a Stronger FDA
About
About Us
Leadership
Members
Join Us
List of Members
Who can Become a Member
Dues Structure
Media
Budget Docs
Contact
Alliance Archives
Join Us
Alliance for a Stronger FDA
About
About Us
Leadership
Members
Join Us
List of Members
Who can Become a Member
Dues Structure
Media
Budget Docs
Contact
Alliance Archives
Join Us
Folder: About
Back
About Us
Leadership
Folder: Members
Back
Join Us
List of Members
Who can Become a Member
Dues Structure
Media
Budget Docs
Contact
Alliance Archives
Join Us
Advocacy at a Glance STEVEN GROSSMAN 5/13/16 Advocacy at a Glance STEVEN GROSSMAN 5/13/16

Senate Ag/FDA Appropriations to Be Marked Up May 17 and 19

Read More
Advocacy at a Glance STEVEN GROSSMAN 5/9/16 Advocacy at a Glance STEVEN GROSSMAN 5/9/16

Congress Returns Next Week

Read More
Advocacy at a Glance STEVEN GROSSMAN 4/30/16 Advocacy at a Glance STEVEN GROSSMAN 4/30/16

Senate and House in Recess Next Week

Read More
Advocacy at a Glance STEVEN GROSSMAN 4/22/16 Advocacy at a Glance STEVEN GROSSMAN 4/22/16

Califf Speech to Alliance a Huge Success

Read More
Advocacy at a Glance STEVEN GROSSMAN 4/15/16 Advocacy at a Glance STEVEN GROSSMAN 4/15/16

Full House Appropriations Committee Action and more

Read More
Advocacy at a Glance STEVEN GROSSMAN 4/8/16 Advocacy at a Glance STEVEN GROSSMAN 4/8/16

Appropriations Subcommittee Allocations Coming Soon and more

Read More
Advocacy at a Glance STEVEN GROSSMAN 4/1/16 Advocacy at a Glance STEVEN GROSSMAN 4/1/16

FDA’s Generics Performance Report and more

Read More
Advocacy at a Glance STEVEN GROSSMAN 3/26/16 Advocacy at a Glance STEVEN GROSSMAN 3/26/16

Introduction of FDA-Related Bills Continues

Read More
Advocacy at a Glance STEVEN GROSSMAN 3/19/16 Advocacy at a Glance STEVEN GROSSMAN 3/19/16

Alliance Capitol Hill Advocacy Day is a Success and more

Read More
Advocacy at a Glance STEVEN GROSSMAN 3/12/16 Advocacy at a Glance STEVEN GROSSMAN 3/12/16

FDA to Apply Lean Management Tools to Handling of Combination Products and more

Read More
Advocacy at a Glance STEVEN GROSSMAN 3/4/16 Advocacy at a Glance STEVEN GROSSMAN 3/4/16

National Biomedical Research Act Introduced

Read More
Advocacy at a Glance STEVEN GROSSMAN 2/27/16 Advocacy at a Glance STEVEN GROSSMAN 2/27/16

Details on FDA’s Request for FY 17 FSMA Appropriations and more

Read More
Advocacy at a Glance STEVEN GROSSMAN 2/19/16 Advocacy at a Glance STEVEN GROSSMAN 2/19/16

Alliance FY 17 “Ask” for FDA Funding

Read More
Advocacy at a Glance STEVEN GROSSMAN 2/12/16 Advocacy at a Glance STEVEN GROSSMAN 2/12/16

President’s FY 17 Budget Request for FDA: Disappointing and Alarming and more

Read More
Advocacy at a Glance STEVEN GROSSMAN 2/5/16 Advocacy at a Glance STEVEN GROSSMAN 2/5/16

Obama-Proposed “Cancer Moonshot” Includes Monies for FDA

Read More
Advocacy at a Glance STEVEN GROSSMAN 1/29/16 Advocacy at a Glance STEVEN GROSSMAN 1/29/16

Senator Murray Wants FDA at “Full Throttle;” Pushes Mandatory FDA Funding and more

Read More
Advocacy at a Glance STEVEN GROSSMAN 1/23/16 Advocacy at a Glance STEVEN GROSSMAN 1/23/16

Federal Deficit Certain to Grow Over Next 10 Years and more

Read More
Advocacy at a Glance STEVEN GROSSMAN 1/15/16 Advocacy at a Glance STEVEN GROSSMAN 1/15/16

FY 17 Appropriations Process to Be Speeded Up and more

Read More
Advocacy at a Glance STEVEN GROSSMAN 1/8/16 Advocacy at a Glance STEVEN GROSSMAN 1/8/16

FY17 Appropriations Process Begins

Read More
Advocacy at a Glance STEVEN GROSSMAN 12/18/15 Advocacy at a Glance STEVEN GROSSMAN 12/18/15

FY 16 Appropriations Nears Finale and more

Read More
Newer Posts
Older Posts

The Alliance for a Stronger FDA | 918 14th Street, SE, Apt 1 Washington, DC 20003 | cartier@strengthenfda.org | LinkedIn

The Alliance for a Stronger FDA is an independent, not-for-profit 501(c)(4) corporation registered in the state of Maryland. It is not affiliated with the FDA and current FDA employees can not become members of the Alliance. For information from the FDA, please click here. Copyright 2025, Alliance for a Stronger FDA.